青島雙星(000599.SZ):控股股東擬增持3.2%-4%股份
格隆匯5月6日丨青島雙星(000599.SZ)公佈,公司於2020年4月30日接到公司控股股東雙星集團的通知,雙星集團混改已經取得政府批覆並已在青島產交所掛牌,引入具有支持雙星快速發展所需關鍵資源的戰略投資者並實施員工持股,儘早打造成為“千億級”規模的世界一流企業。
雙星集團基於對公司未來的信心和長期的投資價值,助力公司更快更好的發展,計劃自2020年5月6日起3個月內,通過深交所證券交易系統增持約2652萬-3315萬股公司股票,增持比例不低於公司總股本的3.2%不超過公司總股本的4%。雙星集團目前持有公司股份約2.15億股,佔公司總股本的25.96%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.